Melexis NV

Informe acción ENXTBR:MELE

Capitalización de mercado: €3.3b

Melexis Resultados de beneficios anteriores

Pasado controles de criterios 2/6

Melexis ha aumentado sus beneficios a una tasa media anual de 26.8%, mientras que los beneficios de la industria de Semiconductor han experimentado un crecimiento de 30.7% anual. Los ingresos han ido creciendo a una tasa media de 16.1% al año. La rentabilidad financiera de Melexis es de 35.1%, y sus márgenes netos son de 21.6%.

Información clave

26.8%

Tasa de crecimiento de los beneficios

26.8%

Tasa de crecimiento del BPA

Crecimiento de la industria Semiconductor 23.8%
Tasa de crecimiento de los ingresos16.1%
Rentabilidad financiera35.1%
Margen neto21.6%
Próxima actualización de resultados31 Jul 2024

Actualizaciones de resultados anteriores recientes

Melexis' (EBR:MELE) Solid Earnings May Rest On Weak Foundations

Feb 15
Melexis' (EBR:MELE) Solid Earnings May Rest On Weak Foundations

Recent updates

Shareholders Will Probably Be Cautious Of Increasing Melexis NV's (EBR:MELE) CEO Compensation At The Moment

May 08
Shareholders Will Probably Be Cautious Of Increasing Melexis NV's (EBR:MELE) CEO Compensation At The Moment

Calculating The Fair Value Of Melexis NV (EBR:MELE)

Mar 27
Calculating The Fair Value Of Melexis NV (EBR:MELE)

At €78.60, Is Melexis NV (EBR:MELE) Worth Looking At Closely?

Mar 14
At €78.60, Is Melexis NV (EBR:MELE) Worth Looking At Closely?

Many Would Be Envious Of Melexis' (EBR:MELE) Excellent Returns On Capital

Feb 28
Many Would Be Envious Of Melexis' (EBR:MELE) Excellent Returns On Capital

Melexis' (EBR:MELE) Solid Earnings May Rest On Weak Foundations

Feb 15
Melexis' (EBR:MELE) Solid Earnings May Rest On Weak Foundations

Melexis (EBR:MELE) Has A Pretty Healthy Balance Sheet

Jan 02
Melexis (EBR:MELE) Has A Pretty Healthy Balance Sheet

What Does Melexis NV's (EBR:MELE) Share Price Indicate?

Dec 09
What Does Melexis NV's (EBR:MELE) Share Price Indicate?

Here's Why Melexis (EBR:MELE) Has Caught The Eye Of Investors

Nov 27
Here's Why Melexis (EBR:MELE) Has Caught The Eye Of Investors

Melexis (EBR:MELE) Knows How To Allocate Capital

Nov 15
Melexis (EBR:MELE) Knows How To Allocate Capital

Calculating The Intrinsic Value Of Melexis NV (EBR:MELE)

Nov 03
Calculating The Intrinsic Value Of Melexis NV (EBR:MELE)

Melexis' (EBR:MELE) Dividend Will Be €0.91

Oct 10
Melexis' (EBR:MELE) Dividend Will Be €0.91

Melexis (EBR:MELE) Is Due To Pay A Dividend Of €0.91

Sep 26
Melexis (EBR:MELE) Is Due To Pay A Dividend Of €0.91

Does Melexis (EBR:MELE) Have A Healthy Balance Sheet?

Sep 17
Does Melexis (EBR:MELE) Have A Healthy Balance Sheet?

Melexis (EBR:MELE) Has Announced A Dividend Of €0.91

Sep 02
Melexis (EBR:MELE) Has Announced A Dividend Of €0.91

Melexis (EBR:MELE) Has Announced A Dividend Of €0.91

Aug 19
Melexis (EBR:MELE) Has Announced A Dividend Of €0.91

Melexis' (EBR:MELE) Dividend Will Be €0.91

Aug 05
Melexis' (EBR:MELE) Dividend Will Be €0.91

Melexis (EBR:MELE) Might Become A Compounding Machine

Jul 13
Melexis (EBR:MELE) Might Become A Compounding Machine

Do Melexis' (EBR:MELE) Earnings Warrant Your Attention?

Jun 29
Do Melexis' (EBR:MELE) Earnings Warrant Your Attention?

Estimating The Intrinsic Value Of Melexis NV (EBR:MELE)

Jun 02
Estimating The Intrinsic Value Of Melexis NV (EBR:MELE)

At €99.75, Is Melexis NV (EBR:MELE) Worth Looking At Closely?

Apr 11
At €99.75, Is Melexis NV (EBR:MELE) Worth Looking At Closely?

With EPS Growth And More, Melexis (EBR:MELE) Makes An Interesting Case

Mar 27
With EPS Growth And More, Melexis (EBR:MELE) Makes An Interesting Case

Is It Time To Consider Buying Melexis NV (EBR:MELE)?

Jan 09
Is It Time To Consider Buying Melexis NV (EBR:MELE)?

Here's Why Melexis (EBR:MELE) Has Caught The Eye Of Investors

Dec 24
Here's Why Melexis (EBR:MELE) Has Caught The Eye Of Investors

Is Melexis NV (EBR:MELE) Expensive For A Reason? A Look At Its Intrinsic Value

Nov 24
Is Melexis NV (EBR:MELE) Expensive For A Reason? A Look At Its Intrinsic Value

Melexis (EBR:MELE) Is Paying Out A Dividend Of €0.91

Oct 18
Melexis (EBR:MELE) Is Paying Out A Dividend Of €0.91

Melexis' (EBR:MELE) Dividend Will Be €0.91

Oct 04
Melexis' (EBR:MELE) Dividend Will Be €0.91

Melexis' (EBR:MELE) Dividend Will Be €0.91

Sep 20
Melexis' (EBR:MELE) Dividend Will Be €0.91

We Ran A Stock Scan For Earnings Growth And Melexis (EBR:MELE) Passed With Ease

Sep 19
We Ran A Stock Scan For Earnings Growth And Melexis (EBR:MELE) Passed With Ease

Melexis' (EBR:MELE) Dividend Will Be €0.91

Sep 05
Melexis' (EBR:MELE) Dividend Will Be €0.91

Melexis (EBR:MELE) Is Due To Pay A Dividend Of €0.91

Aug 22
Melexis (EBR:MELE) Is Due To Pay A Dividend Of €0.91

Melexis (EBR:MELE) Will Pay A Dividend Of €0.91

Aug 04
Melexis (EBR:MELE) Will Pay A Dividend Of €0.91

Is There An Opportunity With Melexis NV's (EBR:MELE) 31% Undervaluation?

Jul 11
Is There An Opportunity With Melexis NV's (EBR:MELE) 31% Undervaluation?

Melexis (EBR:MELE) Looks To Prolong Its Impressive Returns

Jun 27
Melexis (EBR:MELE) Looks To Prolong Its Impressive Returns

Does Melexis (EBR:MELE) Deserve A Spot On Your Watchlist?

Jun 13
Does Melexis (EBR:MELE) Deserve A Spot On Your Watchlist?

Should You Think About Buying Melexis NV (EBR:MELE) Now?

Mar 01
Should You Think About Buying Melexis NV (EBR:MELE) Now?

Calculating The Fair Value Of Melexis NV (EBR:MELE)

Feb 14
Calculating The Fair Value Of Melexis NV (EBR:MELE)

Melexis (EBR:MELE) Looks To Prolong Its Impressive Returns

Dec 06
Melexis (EBR:MELE) Looks To Prolong Its Impressive Returns

Should You Think About Buying Melexis NV (EBR:MELE) Now?

Nov 18
Should You Think About Buying Melexis NV (EBR:MELE) Now?

Is Melexis NV (EBR:MELE) Expensive For A Reason? A Look At Its Intrinsic Value

Sep 29
Is Melexis NV (EBR:MELE) Expensive For A Reason? A Look At Its Intrinsic Value

Does Melexis (EBR:MELE) Have A Healthy Balance Sheet?

Sep 15
Does Melexis (EBR:MELE) Have A Healthy Balance Sheet?

Melexis (EBR:MELE) Will Be Hoping To Turn Its Returns On Capital Around

Jul 18
Melexis (EBR:MELE) Will Be Hoping To Turn Its Returns On Capital Around

Is It Time To Consider Buying Melexis NV (EBR:MELE)?

Jun 21
Is It Time To Consider Buying Melexis NV (EBR:MELE)?

These 4 Measures Indicate That Melexis (EBR:MELE) Is Using Debt Safely

Jun 08
These 4 Measures Indicate That Melexis (EBR:MELE) Is Using Debt Safely

Melexis NV's (EBR:MELE) Intrinsic Value Is Potentially 20% Below Its Share Price

Apr 11
Melexis NV's (EBR:MELE) Intrinsic Value Is Potentially 20% Below Its Share Price

What Is The Ownership Structure Like For Melexis NV (EBR:MELE)?

Mar 17
What Is The Ownership Structure Like For Melexis NV (EBR:MELE)?

Is Melexis (EBR:MELE) Likely To Turn Things Around?

Feb 28
Is Melexis (EBR:MELE) Likely To Turn Things Around?

Does Melexis (EBR:MELE) Have A Healthy Balance Sheet?

Feb 15
Does Melexis (EBR:MELE) Have A Healthy Balance Sheet?

Consider This Before Buying Melexis NV (EBR:MELE) For The 2.8% Dividend

Feb 01
Consider This Before Buying Melexis NV (EBR:MELE) For The 2.8% Dividend

Desglose de ingresos y gastos
Beta

Cómo gana y gasta dinero Melexis. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).

Historial de beneficios e ingresos

ENXTBR:MELE Ingresos, gastos y beneficios (EUR Millions)
FechaIngresosBeneficiosGastos G+AGastos de I+D
31 Mar 2497821171109
31 Dec 2396420972107
30 Sep 2393821268103
30 Jun 239092046698
31 Mar 238811996294
31 Dec 228361975890
30 Sep 227791785585
30 Jun 227221665182
31 Mar 226721524979
31 Dec 216441314778
30 Sep 216251224679
30 Jun 215841004578
31 Mar 21525764477
31 Dec 20508694578
30 Sep 20487614478
30 Jun 20489614579
31 Mar 20509674680
31 Dec 19487604680
30 Sep 19501734680
30 Jun 19525884680
31 Mar 195471014679
31 Dec 185691154578
30 Sep 185601144375
30 Jun 185411124073
31 Mar 185271143871
31 Dec 175121113669
30 Sep 174991093569
30 Jun 174861073367
31 Mar 17470993266
31 Dec 16456963164
30 Sep 16439932963
30 Jun 16426932961
31 Mar 16415952859
31 Dec 15400992857
30 Sep 15386972753
30 Jun 15371972651
31 Mar 15351932547
31 Dec 14332852445
30 Sep 14319812443
30 Jun 14304712443
31 Mar 14289632342
31 Dec 13275552241
30 Sep 13262562141
30 Jun 13255532140

Ingresos de calidad: MELE tiene un alto nivel de ganancias no monetarias.

Margen de beneficios creciente: Los actuales márgenes de beneficio(21.7%) de MELE son inferiores a los del año pasado (23.6%).

Análisis del flujo de caja libre vs. Beneficios

Análisis del crecimiento de los beneficios en el pasado

Tendencia de beneficios: En los últimos 5 años, los beneficios de lMELE han crecido significativamente en un 24.7% al año.

Acelerando crecimiento: El crecimiento de los beneficios de MELE en el último año (6%) está por debajo de su media de 5 años (26.8% al año).

Beneficios vs. Industria: El crecimiento de los beneficios de MELE en el último año (6%) no superó al de la industria Semiconductor 22.8%.

Rentabilidad financiera

Alta ROE: La rentabilidad financiera (35.1%) de MELE se considera alta.

Rentabilidad económica

Rendimiento del capital invertido

Descubre empresas con buenos resultados en el pasado

7D

1Y

7D

1Y

7D

1Y